Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease
{{output}}
As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as ci... ...
